BMPR2 and chronic thromboembolic pulmonary hypertension: While pathogenic variants in the bone morphogenetic protein receptor 2 gene (BMPR2) and related pathway genes [15,16] have been described in patients with pulmonary arterial hypertension (PAH) only two studies reported CTEPH patients with pathogenic variants in the BMPR2 gene [17,18].